Skip to Main Content

Paper Details

Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance.
Proc Natl Acad Sci U S A
57
2018
AsnEDA, AsnEDA 5, P. falciparum, Pf20S, Pf20S 2, Pf20S 5, Pf20S 5 and 2 subunits, Plasmodium falciparum, Plasmodium falciparum proteasome, artemisinin, artemisinins, asparagine ethylenediamine, bortezomib, carfilzomib, erythrocytic, sexual, and liver-stage parasites, human, mice, patients
Author NameAffiliation
Hao Fan
Rong WangMemorial Sloan Kettering Cancer Center
Philip J RosenthalUniversity of California san francisco
  • 1 - 3

Datasets

Release 1.2